Emergence of KPC-producing Klebsiella pneumoniae in Italy

被引：31

作者：

Fontana C. ^{[1
,2
]}

Favaro M. ^{[1
]}

Sarmati L. ^{[4
]}

Natoli S. ^{[3
]}

Altieri A. ^{[2
]}

Bossa M.C. ^{[2
]}

Minelli S. ^{[2
]}

Leonardis F. ^{[3
]}

Favalli C. ^{[1
,2
]}

机构：

[1] Department of Experimental Medicine and Biochemical Sciences, Tor Vergata University of Rome, Rome 00133

[2] Clinical Microbiology Laboratories, Polyclinic of Tor Vergata, Rome 00133

[3] Department of Surgery, Intensive Care Unit, Polyclinic Tor Vergata, Rome 00133

[4] Infectious Diseases, Department of Public Health, Polyclinic of Tor Vergata, Rome 00133

来源：

BMC Research Notes | / 3卷 / 1期

关键词：

Amikacin; Meropenem; Colistin; Teicoplanin; Tigecycline;

D O I：

10.1186/1756-0500-3-40

中图分类号：

学科分类号：

摘要：

Background: The emergence of KPC-producing K. pneumoniae has now become a global concern. KPC beta-lactamases are plasmid-borne and, like extended spectrum beta lactamases (ESBLs), can accumulate and transfer resistance determinants to other classes of antibiotics. Therefore, infection control guidelines on early identification and control of the spread of organisms carrying these resistant determinants are needed. Findings. Klebsiella pneumoniae carbapenemase (KPC) was detected in two isolates of carbapenem-resistant K. pneumoniae obtained from patients at an Italian teaching hospital. The first strain was isolated from a culture drawn from a central venous device (CVC) in a patient with Crohn's disease who was admitted to a gastroenterology ward. The second was isolated from a urine sample collected from an indwelling urinary catheter in an intensive care unit (ICU) patient with a subdural haematoma. The patients had not travelled abroad. Both isolates were resistant to all -lactams and were susceptible to imipenem and meropenem but resistant to ertapenem. Isolates also showed resistance to other classes of non - lactam antibiotics, such as quinolones, aminoglycosides (with the exception for amikacin), trimethoprim-sulfamethoxazole (TMP-SMX) and nitrofurantoin. They were determined to contain the plasmid encoding the carbapenemase gene bla-KPC and were also positive in the Hodge test. Conclusions. This is the second report of KPC-producing isolates in Italy, but the first concerning KPC type 2 gene, and it may have important implications for controlling the transmission of microorganisms resistant to antibiotics. © 2010 Fontana et al; licensee BioMed Central Ltd.

引用

共 31 条

[1]

Wolter D.J., Kurpiel P.M., Woodford N., Palepou M.F., Goering R.V., Hanson N.D., Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4, Antimicrob Agents Chemother, 53, pp. 557-62, (2009)

[2]

Queenan A.M., Bush K., Carbapenemases: The versatile beta-lactamases, Clin Microbiol Rev, 20, pp. 440-58, (2007)

[3]

Yigit H., Queenan A.M., Anderson G.J., Domenech-Sanchez A., Biddle J.W., Steward C.D., Alberti S., Bush K., Tenover F.C., Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae, Antimicrob Agents Chemother, 45, pp. 1151-1161, (2001)

[4]

Villegas M.V., Lolans K., Correa A., Kattan J.N., Lopez J.A., Quinn J.P., First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase, Antimicrob Agents Chemother, 51, pp. 1553-1555, (2007)

[5]

Bratu S., Landman D., Alam M., Tolentino E., Quale J., Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York, Antimicrob Agents Chemother, 49, pp. 776-778, (2005)

[6]

Hossain A., Ferraro M.J., Pino R.M., Ii D.B.I.R., Moland E.S., Lockhart T.J., Thomson K.S., Goering R.V., Hanson N.D., Plasmid mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp, Antimicrob Agents Chemother, 48, pp. 4438-4440, (2004)

[7]

Miriagou V., Tzouvelekis L.S., Rossiter S., Tzelepi E., Angulo F.J., Whichard J.M., Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2, Antimicrob Agents Chemother, 47, pp. 1297-1300, (2003)

[8]

Cai J.C., Zhou H.W., Zhang R., Chen G.X., Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital, Antimicrob Agents Chemother, 52, pp. 2014-2018, (2008)

[9]

Villegas M.V., Lolans K., Correa A., Suarez C.J., Lopez J.A., Vallejo M., Quinn J.P., First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America, Antimicrob Agents Chemother, 50, pp. 2880-2882, (2006)

[10]

Rasheed J.K., Biddle J.W., Anderson K.F., Washer L., Chenoweth C., Perrin J., Newton D.W., Patel J.B., Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and Klebsiella oxytoca carrying a common plasmid, J Clin Microbiol, 46, pp. 2066-2069, (2008)

← 1 2 3 4 →